Search

everythinglearnresearchcommunity

for

Search:↓

Phosphatidylinositol 4-kinases are crucial for root growth, defense, and immunity in Arabidopsis thaliana.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Three compounds from Dadap leaves may help treat hair loss.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Blocking mTORC1 activity could increase hair pigmentation and potentially reverse greying.

Two new compounds were found to effectively reduce hair growth in mice.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Isoalantolactone promotes hair growth by activating specific cell pathways.

DFMO may help control hair growth and treat cancer.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Ruxolitinib can cause a delayed skin reaction on the nose.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

AMPK activation may reduce melanoma risk in red-haired individuals.

Minoxidil can reduce functions related to androgen receptors.